CEPI Covid-19 Vaccine Research Update | Avast

CEPI Covid-19 Vaccine Research Update | Avast
Grace Roberts, 8 December 2020

Discussing the Covid-19 vaccine, the new COVAX initiative, and immunization goals for 2021



The Coalition for Epidemic Preparedness Innovations (CEPI) was formed in 2017, which resulted in over 28,000 Ebola cases and claimed 11,000 lives. It was clear that we, as an international community, needed better preparedness against infectious diseases, particularly in regards to the creation and distribution of vaccines.
CEPI developed as a collaborative effort among the governments of Norway and India, the Bill & Melinda Gates Foundation, the Wellcome Trust, and the World Economic Forum. Since its launch, however, it has gained the financial support of many more national governments, including that of the United States, through the U.S. Agency for International Development (USAID) and the UK, as well as the European Commission. It is also now being supported by the private sector.
When we at Avast were deciding how to allocate our Covid-19 relief effort funds, we carefully reviewed all the fine groups working to end the pandemic, and CEPI quickly rose to the top of the list. Avast proudly made an $8M donation to CEPI and we were told the entire amount went directly to the heart of the effort: vaccine development. 
What exactly does CEPI do? 
In short, it facilitates and funds vaccines, giving researchers the resources they need to move as quickly and productively as they can. The group’s response to Covid-19 was immediate, working with its three golden principles of Speed, Scale, and Access. Currently, it has nine Covid-19 vaccines in development, with eight already in clinical testing. The vaccines that CEPI has supported include Moderna in the U.S. ..

Support the originator by clicking the read the rest link below.